Muley, T.;Schneider, M.;Meister, M.;Thomas, M.;Heussel, C.;Kriegsmann, M.;Holdenrieder, S.;Wehnl, B.;Rolny, V.;Mang, A.;Gerber, R.;Herth, F..Serum Biomarkers Enhance Prognostic Value of Computed Tomography (CT) in Patients With Non-Small Cell Lung Cancer (NSCLC).J Thorac Oncol.2021.16 Suppl S.10.S1028-S1029

Nassar, Y. M.;Ojara, F. W.;Holdenrieder, S.;Krueger, K.;Joerger, M.;Michelet, R.;Huisinga, W.;Kloft, C..Prognostic impact of five serum biomarkers in patients with advanced non-small cell lung cancer (NSCLC): An exploratory analysis.Ann Oncol.2021.32 Suppl 5.S404-S404

Saafan, Hisham;Alahdab, Ahmad;Michelet, Robin;Gohlke, Linus;Ziemann, Janine;Holdenrieder, Stefan;McLaughlin, Katie-May;Wass, Mark N;Cinatl, Jindrich;Michaelis, Martin;Kloft, Charlotte;Ritter, Christoph A.Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line..Cells.2021.10.4

Oezcueruemez, Mustafa;Katsounas, Antonios;Holdenrieder, Stefan;von Meyer, Alexander;Renz, Harald;Woelfel, Roman.Assessment of SARS-CoV-2 rapid antigen tests.J. Lab. Med..2021.45.3.143-148

Sanin, Veronika;Schmieder, Raphael;Ates, Sara;Schlieben, Lea Dewi;Wiehler, Jens;Sun, Ruoyu;Decker, Manuela;Sander, Michaela;Holdenrieder, Stefan;Kohlmayer, Florian;Friedmann, Anna;Mall, Volker;Feiler, Therese;Dreßler, Arne;Strom, Tim M;Prokisch, Holger;Meitinger, Thomas;von Scheidt, Moritz;Koenig, Wolfgang;Leipold, Georg;Schunkert, Heribert.Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study..Eur J Public Health.2022

Ndrepepa, Gjin;Holdenrieder, Stefan;Bernlochner, Isabell;Kastrati, Adnan.Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes..Clin Res Cardiol.2021

Garrido, Manuel M;Marta, José C;Ribeiro, Ruy M;Pinheiro, Luís C;Holdenrieder, Stefan;Guimarães, João T.Comparison of Three Assays for Total and Free PSA Using Hybritech and WHO Calibrations..In Vivo.2021.35.6.3431-3439

van Rossum, Huub H;Meng, Qing H;Ramanathan, Lakshmi V;Holdenrieder, Stefan.A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives..Clin Chem Lab Med.2022.60.4.553-555

Garrido, Manuel M;Ribeiro, Ruy;Pinheiro, Luís C;Holdenrieder, Stefan;Guimarães, João T.The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers..Clin Chem Lab Med.2021.59.11.1869-1877

Garrido, Manuel M;Bernardino, Rui M;Marta, José C;Holdenrieder, Stefan;Guimarães, João T.Tumour markers in prostate cancer: The post-prostate-specific antigen era..Ann Clin Biochem.2022.59.1.46-58